Shares of cannabinoid resin producer MGC Pharmaceuticals got a little too high for the likes of the stock cops this week.
The ASX issued the pot stock a speeding ticket after its shares jumped from 4.2¢ to 6.3¢ on Monday.
The company said there was nothing to report other than it believes the recent "news flow" about its product releases.
Plus the news that "Victoria became the first state in Australia to legalise the use of medicinal cannabis for children with severe epilepsy, had led to the increased shareholder interest in MXC".
CBD is sure that MGC will clear the smoke a bit and inform interested investors that its products are for use in the cosmetics industry, not medicinal.
MXC Price at posting:
5.1¢ Sentiment: None Disclosure: Held
